HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carolyn Y Ho Selected Research

Fibrosis (Cirrhosis)

12/2022Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model.
1/2020Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy.
11/2019Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.
1/2018Sex Differences at the Time of Myectomy in Hypertrophic Cardiomyopathy.
1/2018Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
5/2017The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.
1/2017Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy.
1/2016Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
12/2013Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.
5/2013T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carolyn Y Ho Research Topics

Disease

31Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
12/2022 - 03/2009
11Fibrosis (Cirrhosis)
12/2022 - 08/2010
7Heart Failure
10/2020 - 03/2009
6Cardiomyopathies (Cardiomyopathy)
10/2021 - 03/2009
5Heart Arrest (Cardiac Arrest)
01/2020 - 03/2009
5Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
11/2016 - 05/2010
4Disease Progression
10/2021 - 12/2009
4Atrial Fibrillation
10/2020 - 10/2018
4Stroke (Strokes)
01/2020 - 01/2016
4Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2020 - 04/2010
3Cardiomegaly (Heart Hypertrophy)
12/2022 - 11/2005
3Sudden Death
10/2020 - 03/2009
3Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
02/2012 - 05/2006
2Left Ventricular Outflow Obstruction
12/2021 - 12/2020
2Cardiac Arrhythmias (Arrythmia)
01/2021 - 01/2018
2Hypertrophy
12/2013 - 11/2005
1Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
10/2020
1Shock
01/2020
1Heart Diseases (Heart Disease)
01/2018
1Inborn Genetic Diseases (Disease, Hereditary)
01/2016
1Fabry Disease (Fabry's Disease)
05/2010
1familial dilated cardiomyopathy
01/2010
1Glycogen Storage Disease Type IIb
03/2009
1Cicatrix (Scar)
03/2009
1Left Ventricular Dysfunction
03/2009
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
03/2009

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2005
6MYK-461IBA
12/2021 - 01/2020
5Biomarkers (Surrogate Marker)IBA
12/2021 - 08/2010
4Cardiac MyosinsIBA
12/2021 - 05/2010
4myosin-binding protein CIBA
10/2020 - 05/2010
4GadoliniumIBA
11/2019 - 08/2010
3Valsartan (Vals)FDA Link
10/2021 - 05/2017
3Myosins (Myosin)IBA
10/2020 - 01/2016
3ConnectinIBA
01/2020 - 02/2012
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
12/2022 - 08/2014
2Brain Natriuretic Peptide (Natrecor)FDA Link
12/2021 - 01/2017
2Protein Isoforms (Isoforms)IBA
01/2020 - 05/2010
2Angiotensin Receptor AntagonistsIBA
05/2017 - 12/2013
2pro-brain natriuretic peptide (1-76)IBA
01/2017 - 01/2016
2collagen type I trimeric cross-linked peptideIBA
01/2017 - 08/2010
2Diltiazem (Cardizem)FDA LinkGeneric
11/2016 - 02/2015
2procollagen type I carboxy terminal peptide (PICP)IBA
01/2016 - 08/2010
2Losartan (Cozaar)FDA LinkGeneric
01/2016 - 12/2013
2Lysosomal Membrane ProteinsIBA
10/2010 - 03/2009
1AcidsIBA
12/2022
1Cell Surface ReceptorsIBA
12/2022
1Lysophosphatidic Acid ReceptorsIBA
12/2022
1lysophosphatidic acidIBA
12/2022
1sulconazole (Myk)FDA Link
12/2021
1Lamin Type A (Lamin A)IBA
01/2018
1LaminsIBA
01/2018
1FilaminsIBA
10/2017
1integrin-linked kinaseIBA
10/2017
1Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA
10/2017
1PeriostinIBA
01/2017
1Troponin IIBA
01/2017
1Galectin 3 (LGALS3)IBA
01/2017
1Procollagen Type IIBA
01/2017
1Angiotensin IIIBA
12/2013
1CollagenIBA
08/2010
1Carrier Proteins (Binding Protein)IBA
05/2010
1alpha-Galactosidase (Beano)IBA
05/2010
1GlycosphingolipidsIBA
05/2010
1TropomyosinIBA
01/2010
1DNA (Deoxyribonucleic Acid)IBA
05/2006

Therapy/Procedure

10Therapeutics
10/2021 - 12/2009
8Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
10/2021 - 04/2010
3Heart Transplantation (Grafting, Heart)
01/2020 - 03/2009
2Heart-Assist Devices
10/2020 - 01/2020
1Genomic Medicine
03/2014